Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients
出版年份 2016 全文链接
标题
Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients
作者
关键词
-
出版物
LIVER TRANSPLANTATION
Volume 22, Issue 2, Pages 163-170
出版商
Wiley
发表日期
2015-10-30
DOI
10.1002/lt.24365
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases
- (2015) Francesco Barchiesi et al. LIVER TRANSPLANTATION
- Randomized, Double-Blind Trial of Anidulafungin Versus Fluconazole for Prophylaxis of Invasive Fungal Infections in High-Risk Liver Transplant Recipients
- (2014) D.J. Winston et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes
- (2013) John W Baddley et al. BMC INFECTIOUS DISEASES
- Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era
- (2013) Faouzi Saliba et al. CLINICAL TRANSPLANTATION
- Surviving Sepsis Campaign
- (2013) R. Phillip Dellinger et al. CRITICAL CARE MEDICINE
- Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience
- (2013) D. Neofytos et al. Transplant Infectious Disease
- Cost of Invasive Fungal Infections in the Era of New Diagnostics and Expanded Treatment Options
- (2012) Elizabeth Dodds Ashley et al. PHARMACOTHERAPY
- Population Pharmacokinetic Evaluation with External Validation and Bayesian Estimator of Voriconazole in Liver Transplant Recipients
- (2011) Kelong Han et al. CLINICAL PHARMACOKINETICS
- Invasive fungal infections in liver transplantation
- (2011) Xia Liu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The economic costs to United States hospitals of invasive fungal infections in transplant patients
- (2010) Joseph Menzin et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Antifungal Management Practices in Liver Transplant Recipients
- (2010) N. Singh et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Invasive aspergillosis in patients with liver disease
- (2010) Marco Falcone et al. MEDICAL MYCOLOGY
- Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States
- (2010) Aryun Kim et al. MYCOSES
- Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients
- (2010) D. Neofytos et al. Transplant Infectious Disease
- Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients
- (2009) J. Menzin et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Voriconazole Pharmacokinetics in Liver Transplant Recipients
- (2009) H. J. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
- (2009) Ina Scholz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Risk Profile for Invasive Aspergillosis in Liver Transplant Recipients
- (2009) M. Rosenhagen et al. INFECTION
- Prophylaxis With Caspofungin for Invasive Fungal Infections in High-Risk Liver Transplant Recipients
- (2009) Jesus Fortún et al. TRANSPLANTATION
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups
- (2008) Kuo B. Tong et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started